Member Contact: Andrea Douglas
Position: Vice President, Strategy Portfolio & Licensing
Industry: Biotech & Pharmaceuticals
"CSL is a global specialty biopharmaceutical company that aims to identify, develop and commercialise important, new, biotherapeutic products that help to save lives by preventing or treating serious medical conditions. CSL is committed to significantly investing in its future R&D portfolio and capabilities in the areas of immunoglobulins, specialty products, haemophilia products and breakthrough medicines.
CSL's strong commitment to funding research and development of protein based medicines for unmet medical needs underpins its continued growth.
With major facilities in Australia, Germany, Switzerland and the US, CSL has over 14,000 employees working in 30+ countries around the world. More information is available in the Research & Development section of our website.